Patrick Arensdorf: Founder & CEO, Exai Bio

Pat Arensdorf, founder and  CEO of Exai Bio, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Exai is working to develop a next-generation RNA-based platform to deliver actionable insight into cancer biology from a simple blood draw.

Psivant Employees in front of monitor with molecular model.
Psivant Therapeutics

Designing Better Therapeutics, Atom by Atom

Computer chip/molecular design concept animation.

Discovery as a Service

1% Steps for Health Care Reform Policy Brief Authors Portraits
1% Steps for Health Care Reform

Shifting How We Think About Health Care Spending